Blockchain Registration Transaction Record
Silo Pharma Files Patent for Intranasal Compound SPC-14 Targeting Alzheimer’s Symptoms
Silo Pharma announces the filing of a patent application for SPC-14, a novel intranasal compound targeting Alzheimer’s symptoms. Learn more about Silo Pharma's innovative approach to developing therapeutics for underserved conditions.

This news matters as it highlights Silo Pharma's innovative approach in developing novel therapeutics for underserved conditions like Alzheimer's disease. The filing of the patent for SPC-14 signifies a significant step towards addressing cognitive and neuropsychiatric symptoms in Alzheimer’s patients, potentially offering hope for improved treatment options in the future.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0xcbb35da66fda15375824d3de57fef4592bde7c7001b9fe461a0e45edcb98004b |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | tileKuCf-ff8ce5290d447cb6ae2c3645db661d71 |